94159 ⎘
Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
#302SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY
#303Carboxamide Derivatives As Therapeutic Agents
#304N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR
#305Amido compounds and their use as pharmaceuticals
#306Acylation reaction of hydroxyl group
#307MULTI-RING COMPOUNDS AND USES THEREOF
#308Malonic acid sulfonamide derivative and pharmaceutical use thereof
#309Diamine derivatives as inhibitors of leukotriene A4 hydrolase
#310CETP ACTIVITY INHIBITORS
#311Soluble epoxide hydrolase inhibitors, compositions containing such compounds and methods of treatment
#312ANTIBACTERIAL AGENTS
#313NOVEL PRODRUGS
#314Regulating Agent of GPR34 Receptor Function
#315CLASS OF HISTONE DEACETYLASE INHIBITORS
#316Methods For Treatment Of Cognitive And Menopausal Disorders With D-Threo Methylphenidate
#317Pharmaceutical use of substituted amides
#318Potassium channel blockers
#319Benzamide derivatives as bradykinin antagonists
#320SULFONAMIDE DERIVATIVES AS BRADYKININ ANTAGONISTS
#321L-THREONINE DERIVATIVES OF HIGH THERAPEUTIC INDEX
#322Certain Chemical Entities, Compositions, and Methods
#323Benzamide derivatives and uses related thereto
#324L-threonine derivatives of high therapeutic index
#325CPCR Agonists
#326Phenylacetate derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for prevention or treatment of diseases induced by activation of T-type calcium ion channel containing the same as an active ingredient
#327Piperidines and related compounds for the treatment of Alzheimer's disease
#328Rho kinase inhibitors
#329Urea and sulfamide derivatives as inhibitors of TAFIa
#330Method Of Treating Attention Deficit Disorders With D-Threo Methylphenidate
#331Compounds which inhibit members of the histone deacetylase family of enzymes and their use in the treatment of cell proliferative diseases
#332L-Threonine derivatives of high therapeutic index
#333Imidazopyridinyl benzamide mitotic kinesin inhibitors
#334HETEROCYCLO INHIBITORS OF POTASSIUM CHANNEL FUNCTION
#335GSM INTERMEDIATES
#336Imidazopyridinyl benzamide mitotic kinesin inhibitors
#337CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS
#338Non-steroidal progesterone receptor modulators
#339Substituted amides
#340Piperidines and related compounds for the treatment of dementia
#341CYCLOALKENE DERIVATIVES, PROCESS FOR PRODUCTION OF THE DERIVATIVES, AND USE OF THE SAME
#342Compounds IV
#343Cyclic Amine Derivatives, Processes For Their Preparation, And Pharmaceutical Compositions Containing Them
#344Piperidine derivatives for treatment of Alzheimer's disease
#345PARP INHIBITORS
#346Inhibitors of histone deacetylase
#347Secondary amines as renin inhibitors
#348Benzoyl Urea Derivatives
#349N-aryl piperidine substituted biphenylcarboxamides
#350Human adam-10 inhibitors
#351L-Phenylalanine Derivatives
#352Benzylpiperazine derivatives as motilin receptor agonists
#353Therapeutic Agents - 551
#354Process for Preparing Beta-(Fluorophenyl)-Propanoate Ester Derivatives
#355Therapeutic Agents - 550
#356NON-STEROIDAL PROGESTERONE RECEPTOR MODULATORS
#357Plasma carboxypeptidase B inhibitors
#358Chronic, Bolus Adminstration Of D-Threo Methylphenidate
#359DEUTERIUM-ENRICHED METHYLPHENIDATE
#360Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#361Novel Piperidine-4-Acetic Acid Derivatives and Their Use
#362Chemical compounds
#363BENZAMIDE DERIVATIVES USEFUL AS HISTONE DEACETYLASE INHIBITORS
#364Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#365Substituted piperidine compounds and methods of their use
#366Dpp-Iv Inhibitors
#367Process for the Preparation of Alpha-Aryl-Alpha-Piperid-2-Yl-Acetamides and the Acid Hydrolysis Thereof
#368Certain chemical entities, compositions, and methods
#369Amido compounds and their use as pharmaceuticals
#370Hydroxamates as Histone Deacetylase Inhibitors and Pharmaceutical Formulations Containing Them
#371Caspase inhibitor prodrugs
#372Substituted pyridyoxy amides
#373Process of enantiomeric resolution of D,L-(±)-threo-methylphenidate
#374Substituted pyrrolidine and related compounds
#375Substituted pyrrolidine and related compounds
#376POLYARYLCARBOXAMIDES USEFUL AS LIPID LOWERING AGENTS
#377Carboxamide derivatives as therapeutic agents
#378Novel Sulfonamide derivative
#379Lipid lowering biphenylcarboxamides
#380Piperidine Derivative or Pharmaceutically Acceptable Salt Thereof
#381CETP activity inhibitors
#382Piperidines and related compounds for treatment of alzheimer's disease
#383ANDROGEN RECEPTOR MODULATORS AND METHOD OF TREATING DISEASE USING THE SAME
#3842-Cyanopropanoic Acid Amide and Ester Derivatives and Methods of Their Use
#385Modulators of melanocortin receptor
#386Tri(cyclo) substituted amide compounds
#387Glycogen Phosphorylase Inhibitor Compounds and Pharmaceutical Compositions Thereof
#388Hydroxypropyl Amides for the Treatment of Alzheimer's Disease
#389Modulation of Pathogenicity
#390Modulation of Pathogenicity
#391Modulation of Pathogenicity
#392Modulation of Pathogenicity
#393DIPEPTIDE NITRILE CATHESPIN K INHIBITORS
#394Contrast medium for thrombus formation
#395Modulation of Pathogenicity
#396Amido compounds and their use as pharmaceuticals
#397Diamino alcohols and their use as renin inhibitor
#398Meta-benzamidine derivatives as serine protease inhibitors
#399Diamine derivatives as inhibitors of leukotriene Ahydrolase
#400Imidazoyl-benzamide anti-cancer agents
#401Substituted pyrrolidine and related compounds
#402Polypharmacophoric agents
#403Process for production of aromatic compounds
#404Substituted piperazines and piperidines as modulators of the neuropeptide Y2 receptor
#405N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
#406Modulation of Pathogenicity
#407Substituted n-phenyl sulfonamide bradykinin antagonists
#408Polyarylcarboxamides useful as lipid lowering agents
#409Substituted pyrrolidine and related compounds
#410Cyclic amine derivatives, processes for their preparation, and pharmaceutical compositions containing them
#411Apoptosis promoters
#412Aniline derivatives
#413Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors
#414VLA-4 inhibitor compounds
#415Dipiperazinyl ketones and related analogues
#416Apoptosis promoters
#417Androgen receptor modulators and methods of treating disease using the same
#418Benzamide derivatives and uses related thereto
#419Bicyclic substituted phenyl piperidine modulators of muscarinic receptors
#420L-Threonine derivatives of high therapeutic index
#421Cyclopropyl derivatives as NK3 receptor antagonists
#4221,2-di(cyclic) substituted benzene compounds
#423N-(4-(imidazo[1,2A]pyridin-YL)phenethyl)benzamide inhibitors of the mitotic kinesin CENP-E for treating certain cellular proliferation diseases
#424Plasma carboxypeptidase B inhibitors
#425Hydroxamate sulfonamides as cd23 shedding inhibitors
#426Polyarylcarboxamides useful as lipid lowering agents
#427Compounds with high therapeutic index
#428Methods and compositions for treating amyloid-related diseases
#429Hydroxysteroid dehydrogenase inhibitors
#430Process for the hydrogenation of aromatic compounds
#431Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
#432Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
#433Piperidine derivatives and their use as anti-inflammatory agents
#434Substituted piperidine carbamates
#435Isophthalic acid derivatives
#436Processes and intermediates for resolving piperidyl acetamide stereoisomers
#437Method for the production of d-threo-2-phenyl-2-piperidine-2-yl acetates
#438Modulators of dopamine neurotransmission
#439Chemical compounds
#440Process for alkylating secondary amines and the use in donepezil preparation thereof
#441Cyclohexyl compounds as CCR5 antagonists
#442Fused benzene derivative and use
#443Substituted biphenyl-4-carboxylic acid arylamide analogues
#444Process for preparation of benzylpiperidine compounds
#445Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
#446R-isomer of 2-{2[N-(2-indanyl)-N-phenylamino]ethyl}piperidine and other dermal anesthetics
#447Amino substituted aryloxybenzylpiperidine derivatives
#448Novel piperidine derivaties as modulators of chemokine receptor ccr5
#44917β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
#450N-benzyl-3-phenyl-3-heterocyclyl-propionamide compounds as tachykinin and/or serotonin reuptake inhibitors
#451Amine and amide derivatives as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
#452N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
#453Method of treating attention deficit disorders with d-threo methylphenidate
#454Cell adhesion inhibitors
#455Heterocyclo inhibitors of potassium channel function
#45617 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
#457Androgen receptor modulators and method of treating disease using the same
#458Aryl-substituted piperazine derivatives
#459Thyroid receptor ligands and method II
#460Amido compounds and their use as pharmaceuticals
#461Manufacturing process for methyl phenidate and intermediates thereof
#462Serine protease inhibitors
#463Dipeptide nitrile cathepsin K inhibitors
#464Use of ER selective NF-kB inhibitors for the treatment of sepsis
#465Biaromatic compounds which activate PPARγ type receptors and cosmetic/pharmaceutical compositions comprised thereof
#466Phenyl-substituted 4-hydroxy-tetrahydropyridones
#467Substituted amides
#468Human ADAM-10 inhibitors
#469Opioid receptor antagonists
#470Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
#471Serine protease inhibitors
#472Benzamide derivatives
#4732,5-disubstituted 3-mercaptopentanoic acid
#474Prodrugs of potassium channel inhibitors
#475Method to separate stereoisomers
#476Benzamide derivatives useful as histone deacetylase inhibitors
#477MCH antagonists and their use in the treatment of obesity
#478Polyarylcarboxamides useful as lipid lowering agents
#479Compounds useful in the treatment of anthrax and inhibiting lethal factor
#480Guanidine and amidine derivatives as factor Xa inhibitors
#481Optical interleaver
#482Method of treating attention deficit disorders with D-threo methylphenidate
#483Compounds and methods
#484Compounds useful in therapy
#485Naphthalene derivatives
#4865-HTreceptor antagonists
#487Process for preparation of piperidin-2-ylacetic acid
#488Serotonine reuptake inhibitor
#489Acylsulfonamides as inhibitors of steroid sulfatase
#490Chronic, bolus administration of D-threo methylphenidate
#491Process for preparation of benzylpiperidine compounds
#4924-Phenyl-piperidine compounds and their use as modulators of opioid receptors
#493Compounds
#494Processes and intermediates for resolving piperidyl acetamide stereoisomers
#4952-Cyanopropanoic acid amide and ester derivatives and methods of their use